HBGHX — Hartford Healthcare Hls Fund
Data updated: 2026-05-22
HBGHX — Hartford Healthcare Hls Fund data: holdings, portfolio allocation, expenses, performance, cashflows, risk and SEC filings. United States Health Care Equity · $104.45M AUM · 1.19% expense ratio · 9.3% 1-yr return. From SEC regulatory filings.
HBGHX Fund Overview
HBGHX — Hartford Healthcare Hls Fund is a US mutual fund managed by Hartford Series Fund INC, categorised as United States Health Care Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: Hartford Series Fund INC
- Category: United States Health Care Equity
- Assets under management: $104.45M
- 1-year return: 9.3%
- Ticker: HBGHX
- SEC CIK: 0001053425
- SEC series ID: S000003206
- Share class ID: C000008599
HBGHX Holdings
Top 10 holdings of Hartford Healthcare Hls Fund by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Eli Lilly & Co | 12.09% |
| Merck & Co Inc | 6.71% |
| Johnson & Johnson | 6.05% |
| UnitedHealth Group Inc | 4.11% |
| Intuitive Surgical Inc | 3.53% |
| AbbVie Inc | 3.19% |
| Abbott Laboratories | 2.88% |
| Danaher Corp | 2.84% |
| Edwards Lifesciences Corp | 2.73% |
| Vertex Pharmaceuticals Inc | 2.50% |
HBGHX Portfolio Allocation
Asset-class allocation of Hartford Healthcare Hls Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 99.4% |
| Cash & Equivalents | 0.7% |
HBGHX Performance
Total returns for HBGHX (as of 2026-08-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | -5.0% |
| 1 year | 9.3% |
| 3 years (annualised) | 5.9% |
| 5 years (annualised) | 2.3% |
HBGHX Risk Information
Risk metrics for HBGHX, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 16.7%
HBGHX Costs and Fees
HBGHX costs about $119 per $10,000 invested per year in fund expenses.
- Net expense ratio: 1.19%
- Gross expense ratio: 1.19%
- Portfolio turnover: 50%
- Brokerage commissions: 4.22 bps of average net assets (SEC N-CEN)
HBGHX Cashflows
Over the 12 months to 2026-03, Hartford Healthcare Hls Fund had net outflows of $12.46M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-03 | −$1.57M |
| 2026-02 | −$2.35M |
| 2026-01 | −$1.56M |
| 2025-12 | −$1.72M |
| 2025-11 | −$1.62M |
| 2025-10 | −$2.36M |
HBGHX Debt Constituents
No individual debt constituents are reported in Hartford Healthcare Hls Fund's latest SEC N-PORT filing.
HBGHX Prospectus and SEC Filings
Official Hartford Healthcare Hls Fund filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Other United States Health Care Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.